Accounting Errors and Accounting Falsifications: The Case of Kangmei Pharmaceuticals

Yaqi Liu ； Kai Ding ； Zihang Fu ； Xiao Chen ； Zejiong Zhou

《Frontiers in Economics and Management》 3卷6期 (2022/06) Pp. 593-599

https://doi.org/10.6981/FEM.202206_3(6).0068

摘要

In view of the financial fraud of listed companies, this paper takes Kangmei Pharmaceutical Co., Ltd. which uses huge accounting error adjustment to conceal the fact of financial fraud as an example. Firstly sorts out the risk factors of the company's fraud, analyzes the fraudulent practices of the company, and analyzes the reasons why the fraud was not detected by the accounting firm of Zhujiang Zhengzhong, and finally elaborates the effective preventive measures of audit failure from three aspects: the auditor, the financial fraudster and the supervisor.

關鍵字

Financial Fraud Audit Failure ； Fraud Triangle Theory ； Comet Pharmaceuticals

參考文獻

Lu Jianqiao. Accounting and auditing in the post-Enron era: A review of the Sarbanes-Oxley Act of 2002 in the United States [J]. Accounting Research, 2002(10).

Ge Jiashu. Analysis of the Economic Background of the Enron Incident in the United States [J]. Accounting Research, 2003(1).

Huang, S.C., Chen, J. M. Exploring the crux of financial fraud in the United States [J]. Accounting Research, 2002(10).

Liu Hua. The audit failure of LNST and the trust crisis of Chinese concept stocks [J]. Finance and Accounting, 2012(2).

Yuan Min. Analysis and inspiration of the Southeast Rongtong incident [J]. Finance and Accounting. 2012(1).